Monitoring polymedicated elderly patients in a health care unit

C. Galán-Retamal, R. Garrido-Fernández, S. Fernández-Espínola, V. Padilla-Marín
{"title":"Monitoring polymedicated elderly patients in a health care unit","authors":"C. Galán-Retamal,&nbsp;R. Garrido-Fernández,&nbsp;S. Fernández-Espínola,&nbsp;V. Padilla-Marín","doi":"10.1016/S2173-5085(10)70019-8","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To implement a coordinated strategy for the family care unit and the pharmacy division in order to enable revising treatment in polymedicated patients. To this end, we have developed a software tool permitting the patient's primary doctor to have a quick, summarised description of the patient's updated pharmacological treatments, and detect iatrogenic risks and/or dosage adjustments and pharmacotherapy advice.</p></div><div><h3>Methods</h3><p>In this study, polymedicated patients are defined as those taking 10 or more medications during at least one month.</p><p>Development phases:</p><p>Designing a guide form to assist the family doctor in reviewing treatments.</p><p>Developing a drug treatment report (DTR) as a complementary document to assist the doctor in reviewing treatments.</p><p>Introducing a coordinated communication system between the family doctor and the pharmacist.</p><p>Reviewing work instructions and distributing them to staff members involved.</p></div><div><h3>Results</h3><p>The target population of the study consists of 1897 polymedicated patients. We issued 1897 reports, containing the following: 8530 recommendations (10% alerts from regulatory authorities, 31% recommendations regarding high-risk drugs in elderly patients, 7% gave information about new treatments and 52% recommendations on proper drug use); 399 had high clinically relevant drug interactions; and 5036 dose adjustment recommendations. These pharmacotherapy reports allow treatment to be revised for nearly 100% of the selected population.</p></div><div><h3>Conclusion</h3><p>The development and implementation of software tools for monitoring polymedicated patients enables us to create DTRs that facilitate routine medical reviews of pharmacological treatment in a fairly wide range of patients.</p></div>","PeriodicalId":100521,"journal":{"name":"Farmacia Hospitalaria (English Edition)","volume":"34 6","pages":"Pages 265-270"},"PeriodicalIF":0.0000,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2173-5085(10)70019-8","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmacia Hospitalaria (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2173508510700198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective

To implement a coordinated strategy for the family care unit and the pharmacy division in order to enable revising treatment in polymedicated patients. To this end, we have developed a software tool permitting the patient's primary doctor to have a quick, summarised description of the patient's updated pharmacological treatments, and detect iatrogenic risks and/or dosage adjustments and pharmacotherapy advice.

Methods

In this study, polymedicated patients are defined as those taking 10 or more medications during at least one month.

Development phases:

Designing a guide form to assist the family doctor in reviewing treatments.

Developing a drug treatment report (DTR) as a complementary document to assist the doctor in reviewing treatments.

Introducing a coordinated communication system between the family doctor and the pharmacist.

Reviewing work instructions and distributing them to staff members involved.

Results

The target population of the study consists of 1897 polymedicated patients. We issued 1897 reports, containing the following: 8530 recommendations (10% alerts from regulatory authorities, 31% recommendations regarding high-risk drugs in elderly patients, 7% gave information about new treatments and 52% recommendations on proper drug use); 399 had high clinically relevant drug interactions; and 5036 dose adjustment recommendations. These pharmacotherapy reports allow treatment to be revised for nearly 100% of the selected population.

Conclusion

The development and implementation of software tools for monitoring polymedicated patients enables us to create DTRs that facilitate routine medical reviews of pharmacological treatment in a fairly wide range of patients.

在卫生保健单位监测使用多种药物的老年患者
目的实施家庭护理单位与药学部门的协调策略,使多药患者的治疗得以改进。为此,我们开发了一种软件工具,使患者的主治医生能够快速、概括地描述患者最新的药物治疗情况,并检测医源性风险和/或剂量调整和药物治疗建议。方法在本研究中,多重用药患者定义为在至少一个月内服用10种或10种以上药物的患者。开发阶段:设计指导表格,帮助家庭医生评估治疗方案。制定药物治疗报告(DTR)作为补充文件,以协助医生审查治疗。引入家庭医生与药剂师之间的协调沟通系统。审查工作指示并分发给相关员工。结果本研究的目标人群为1897例综合用药患者。我们发布了1897份报告,包含以下内容:8530条建议(10%来自监管部门的警告,31%关于老年患者高风险药物的建议,7%提供新治疗信息,52%关于正确用药的建议);399例临床相关药物相互作用高;5036个剂量调整建议。这些药物治疗报告允许对几乎100%的选定人群的治疗进行修订。结论开发和实施用于监测多种药物患者的软件工具使我们能够创建dtr,从而促进对相当大范围患者的药物治疗进行常规医学审查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信